pharma · Pulmonary Arterial Hypertension (PAH)
AOP Orphan Pharmaceuticals
AOP Orphan Pharmaceuticals GmbH
AOP Orphan Pharmaceuticals clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Wien, AT HQ
EMA registrant Type
Company details
- Status
- Public
- HQ
- Wien, AT
- Programs
- 2
- Drugs
- 1
- Patents
- 7
AOP Orphan Pharmaceuticals projects
2 ClinicalTrials.gov programs sponsored by AOP Orphan Pharmaceuticals.
AOP Orphan Pharmaceuticals has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does AOP Orphan Pharmaceuticals have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.